(1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2′-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate (as per EP) ; 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate; Candesartan Cilexetil USP Related Compound D ; Candesartan Cilexetil N2-Ethyl Amide ; Candesartan Cilexetil O-Desethyl N2-Ethyl Analog ; 2-Desethoxy-2-Hydroxy-2H-N2-Ethyl Candesartan Cilexetil
Candesartan Cilexetil EP Impurity D is a fully characterized chemical compound used as a reference standard of API Candesartan. The standard offered is compliant with regulatory guidelines. Candesartan Cilexetil EP Impurity D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1185256-03-4
